VICTORY CAPITAL MANAGEMENT INC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 79 filers reported holding UTAH MED PRODS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$166,324
-7.7%
1,9340.0%0.00%
Q2 2023$180,249
+105.0%
1,934
+108.4%
0.00%
Q1 2023$87,947
-5.7%
9280.0%0.00%
Q4 2022$93,292
+7.2%
928
-9.3%
0.00%
Q3 2022$87,000
-2.2%
1,023
-1.3%
0.00%
Q2 2022$89,000
-8.2%
1,036
-4.0%
0.00%
Q1 2022$97,000
-5.8%
1,079
+4.8%
0.00%
Q4 2021$103,000
+6.2%
1,030
-1.9%
0.00%
Q3 2021$97,000
-3.0%
1,050
-11.0%
0.00%
Q2 2021$100,000
-2.0%
1,1800.0%0.00%
Q1 2021$102,000
-68.1%
1,180
-65.2%
0.00%
Q1 2020$320,000
+75.8%
3,392
+101.4%
0.00%
Q4 2019$182,000
+40.0%
1,684
+23.7%
0.00%
Q3 2019$130,0001,3610.00%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Penn Mutual Asset Management 36,283$3,120,3382.93%
Clean Yield Group 31,263$2,684,5541.19%
BARD ASSOCIATES INC 18,181$1,563,5660.65%
RICE HALL JAMES & ASSOCIATES, LLC 111,634$9,600,5240.61%
Ranger Investment Management 74,411$6,399,3460.42%
ISTHMUS PARTNERS, LLC 21,307$1,832,4020.26%
Cardinal Capital Management 11,581$999,3440.20%
Riverwater Partners LLC 2,354$202,4440.18%
GLOBEFLEX CAPITAL L P 9,338$803,0680.09%
JAMES INVESTMENT RESEARCH INC 4,292$369,1120.05%
View complete list of UTAH MED PRODS INC shareholders